Back to Infectious Disease
Infectious DiseasevCDCEvidence-Based

Tuberculin Skin Test (TST) Interpretation

Interprets the tuberculin skin test (Mantoux) by induration size using CDC risk-stratified cutoffs: ≥5 mm positive in highest-risk groups (HIV, contacts, immunosuppressed, fibrotic CXR, transplant); ≥10 mm in moderate-risk groups; ≥15 mm in persons with no risk factors.

Clinical Input Parameters

mm
Range: 0 — 50 mm
Clinical Assessment
Awaiting Parameters
tst positive
—class
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The Tuberculin Skin Test (TST) Interpretation is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within infectious disease.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

Positive if induration ≥ cutoff for the risk group (5 / 10 / 15 mm)

Clinical Pearls & Practice Notes

  • Risk groups per CDC: 5 mm — HIV infection, recent TB contacts, fibrotic changes on chest X-ray, immunosuppressed (e.g. TNF-alpha blockers, prolonged steroids), organ transplant recipients. 10 mm — recent immigrants from high-prevalence countries, injection drug users, residents/employees of high-risk congregate settings, mycobacteriology lab personnel, children <4 years, infants/children/adolescents exposed to high-risk adults. 15 mm — persons with no known risk factors.
  • Read induration (not erythema) 48-72 hours after placement.
  • BCG vaccination history does not change the interpretation cutoffs; IGRA is preferred if BCG confounds.

Evidence & Literature Citations

  1. Centers for Disease Control and Prevention (CDC). Guidelines for interpreting the tuberculin skin test (Mantoux): 5/10/15 mm risk-stratified cutoffs. CDC latent TB infection guidance.

Score Interpretation Ranges

Negative0 – 0 pts

TST negative

Positive1 – 1 pts

TST positive

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.